Rate My Professor Philip Evans

Evans specializes in the application of physics and engineering to medical imaging problems, particularly in radiotherapy. His research encompasses quantitative radiomics methods for cancer applications, such as lung cancer biomarkers using metabolism and texture features; imaging during breast radiotherapy treatment as in the IMPORT HIGH trial; standardisation of imaging and treatment in MRI-guided radiotherapy in collaboration with Elekta and the National Physical Laboratory; ultrasound approaches for image-guided brachytherapy; and proton beam radiotherapy imaging methods as part of the Pravda consortium for 3D proton beam images. Key publications include 'Assessing small-lesion detectability and acquisition time optimisation in silicon-detector-Based PET: a phantom study' (Nicholas Thomas Leybourne et al., 2025); 'Enhanced performance characteristics of digital PET for small feature detection relative to non-digital PET' (Nicholas Leybourne et al., 2024); 'Models of the light output from scintillation crystals' (P. Evans and A. Mosleh-Shirazi, 2005); 'Tumour bed delineation for partial breast/breast boost radiotherapy: What is the optimal number of implanted markers?' (AM Kirby et al., 2013); and 'Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results' (Charlotte E. Coles et al., 2017, The Lancet). His work has contributed to advancements in accurate radiotherapy delivery and clinical trials influencing breast cancer treatment protocols.